Home Tags Palforzia (AR101)

AIM_Palforzia_SnackSafely_Article_Holiday_imagesFamily

This Holiday Season, See the Potential Impact that Peanut Allergy Treatment...

Aimmune - 2021/12/07 0

Notebooks, check. Backpack, check. Peanut allergy treatment, check.

Aimmune - 2021/10/05 0

USF Begins Recruitment for OIT Study Addressing 15 Food Allergies at...

Dave Bloom - 2021/09/06 0

Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts...

News Wire ~ 3rd Party Press Release - 2021/08/05 0

How the First FDA-Approved Therapy for Peanut Allergy is Helping Families

Aimmune - 2021/03/17 0

Aimmune Presents New Clinical Data From Patients Treated With PALFORZIA® for...

News Wire ~ 3rd Party Press Release - 2021/02/25 0

Peanut Allergy More Common in Adults Than Children, Many Report First...

News Wire ~ 3rd Party Press Release - 2021/02/09 0

Nestlé to Acquire Aimmune Therapeutics

News Wire ~ 3rd Party Press Release - 2020/08/31 0

Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...

News Wire ~ 3rd Party Press Release - 2020/07/21 0

New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...

News Wire ~ 3rd Party Press Release - 2020/06/08 0

123 Page 2 of 3

Put Your School on the Map

Dave Bloom - 2024/07/31 0

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Palforzia (AR101)